Founded in 2014, Hadean Ventures is a Norway-based investment firm focusing on life science and healthcare sectors across Europe. With offices in Oslo and Stockholm, the company collaborates with leading academic institutions to invest in innovative startups addressing unmet medical needs.
CardioMech develops therapeutic devices for structural heart disease. Its flagship technology offers a transcatheter alternative to cardiac surgery for the placement of artificial chords in the mitral valve, enabling surgeons to treat patients with severe, symptomatic degenerative mitral regurgitation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.